Private Capital Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $66K | Sell |
233
-28
| -11% | -$7.93K | 0.05% | 381 |
|
|
2022
Q1 | $68K | Buy |
261
+4
| +2% | +$1.04K | 0.02% | 537 |
|
|
2021
Q4 | $56K | Sell |
257
-16
| -6% | -$3.49K | 0.01% | 635 |
|
|
2021
Q3 | $50K | Sell |
273
-12
| -4% | -$2.2K | 0.01% | 677 |
|
|
2021
Q2 | $58K | Buy |
285
+20
| +8% | +$4.07K | 0.01% | 616 |
|
|
2021
Q1 | $57K | Sell |
265
-253
| -49% | -$54.4K | 0.01% | 587 |
|
|
2020
Q4 | $122K | Buy |
518
+17
| +3% | +$4K | 0.02% | 438 |
|
|
2020
Q3 | $136K | Sell |
501
-284
| -36% | -$77.1K | 0.03% | 366 |
|
|
2020
Q2 | $228K | Buy |
785
+151
| +24% | +$43.9K | 0.05% | 255 |
|
|
2020
Q1 | $151K | Buy |
634
+18
| +3% | +$4.29K | 0.04% | 307 |
|
|
2019
Q4 | $134K | Buy |
616
+93
| +18% | +$20.2K | 0.03% | 365 |
|
|
2019
Q3 | $89K | Buy |
523
+255
| +95% | +$43.4K | 0.02% | 522 |
|
|
2019
Q2 | $46K | Buy |
268
+16
| +6% | +$2.75K | 0.01% | 706 |
|
|
2019
Q1 | $46K | Sell |
252
-1
| -0.4% | -$183 | 0.01% | 818 |
|
|
2018
Q4 | $42K | Buy |
253
+3
| +1% | +$498 | 0.01% | 754 |
|
|
2018
Q3 | $48K | Sell |
250
-18
| -7% | -$3.46K | 0.01% | 741 |
|
|
2018
Q2 | $45K | Sell |
268
-18
| -6% | -$3.02K | 0.01% | 745 |
|
|
2018
Q1 | $47K | Sell |
286
-3,094
| -92% | -$508K | 0.01% | 716 |
|
|
2017
Q4 | $12 | Buy |
+3,380
| New | +$12 | ﹤0.01% | 1291 |
|